Why Is Robotic Surgery-Focused Penny Stock Asensus Surgical Trading Higher On Friday?
Why Is Robotic Surgery-Focused Penny Stock Asensus Surgical Trading Higher On Friday?
On Friday, KARL STORZ Endoscopy-America, Inc. agreed to acquire Asensus Surgical Inc. (NYSE:ASXC) for $0.35 per share in cash.
週五，KARL STORZ內窺鏡設備-美國公司同意收購Asensus Surgical Inc.（紐交所：ASXC）的現金股票每股0.35美元。
KARL STORZ is a wholly-owned direct subsidiary of KARL STORZ SE & Co. KG, an independent, family-owned global medical technology company based in Germany.
KARL STORZ是KARL STORZ SE＆Co. KG的全資直接子公司，後者是一家獨立的，家族式的總部位於德國的全球醫療科技公司。
The purchase price represents a premium of approximately 67% based on the per-share closing price of the Asensus common stock on the NYSE American on April 2 and a premium of approximately 52% to the closing price of the common stock on the last trading day prior to the date of this announcement.
購買價格基於Asensus普通股在4月2日紐交所美國交易日收盤價的每股收盤價，代表了約67％的溢價，並且基於本公告日期之前最後一個交易日普通股的收盤價的溢價約爲52％。
In April, Asensus entered into a non-binding letter of intent with KARL STORZ to engage in diligence and negotiations.
4月，Asensus與KARL STORZ簽署了一份非約束性意向書進行盡職調查和談判。
Asensus' Board has unanimously approved the transaction of Directors.
Asensus的董事會一致批准了本次交易。
The transaction would enhance KARL STORZ's portfolio and market presence, strengthening KARL STORZ's position in the robotic surgical market, particularly with the development of the next-generation LUNA system.
該交易將增強KARL STORZ的組合和市場存在感，增強KARL STORZ在機器人手術市場的地位，特別是在開發下一代LUNA系統方面。
The transaction is anticipated to close during the third quarter of 2024.
預計該交易將在2024年第三季度結束。
Upon completion of the transaction, Asensus Surgical will become a subsidiary of KARL STORZ Endoscopy-America and no longer be publicly listed or traded on the NYSE American Exchange.
交易完成後，Asensus Surgical將成爲KARL STORZ內窺鏡設備-美國的子公司，不再在紐交所美國交易所公開上市或交易。
In April, Asensus secured a loan of up to $20 million from KARL STORZ to support operations during the exclusivity period and potential transaction process.
四月，Asensus從KARL STORZ獲得了高達2000萬美元的貸款，以支持獨家期內的營運和潛在交易進程。
This loan will provide up to $10 million of liquidity during exclusivity. The medical device company said that if a definitive merger agreement is successfully negotiated and executed, additional funding in an aggregate amount of up to $10 million will be available under the loan.
這項貸款將在獨家期內提供多達1000萬美元的流動資金。該醫療器械公司表示，如果成功談判並執行明確的合併協議，該貸款將提供多達1000萬美元的額外資金。
Asensus generated first-quarter 2024 revenues of $1.1 million.
Asensus在2024年第一季度實現了110萬美元的收入。
Price Action: ASXC shares are up 41.40% at $0.33 at the last check on Friday.
股票價格：截至上週五，ASXC股票上漲了41.40％，至0.33美元/股。